Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FERRARO, Donatella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.901
EU - Europa 1.960
AS - Asia 818
AF - Africa 21
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 7.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.874
IT - Italia 639
CN - Cina 454
FI - Finlandia 359
UA - Ucraina 289
SG - Singapore 278
IE - Irlanda 149
DE - Germania 128
GB - Regno Unito 103
SE - Svezia 84
RU - Federazione Russa 73
BE - Belgio 32
FR - Francia 26
IN - India 25
CA - Canada 24
RO - Romania 21
CI - Costa d'Avorio 16
KR - Corea 14
TR - Turchia 13
IR - Iran 11
NL - Olanda 11
HK - Hong Kong 9
CZ - Repubblica Ceca 8
ES - Italia 7
CH - Svizzera 6
AT - Austria 5
AU - Australia 4
SN - Senegal 4
PL - Polonia 3
TW - Taiwan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BR - Brasile 2
BY - Bielorussia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
MX - Messico 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EE - Estonia 1
GM - Gambi 1
ID - Indonesia 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 7.710
Salva come PNG Salva come JPEG
Città #
Fairfield 714
Chandler 452
Ashburn 416
Woodbridge 389
Wilmington 290
Ann Arbor 275
Houston 275
Seattle 259
Cambridge 235
Singapore 223
Palermo 159
Jacksonville 154
Dublin 149
Medford 137
Des Moines 129
Nanjing 110
Altamura 88
Princeton 83
Lawrence 63
Boardman 59
San Diego 50
Shenyang 41
Tulsa 41
Beijing 39
Brussels 31
Milan 31
Dearborn 29
Nanchang 29
New York 28
London 26
Changsha 23
Hebei 22
Jinan 22
Ottawa 22
Jiaxing 20
Santa Clara 17
Abidjan 16
Los Angeles 16
Ludwigshafen am Rhein 15
Ningbo 15
Saint Petersburg 15
Kumar 14
Zhengzhou 14
Helsinki 13
Izmir 12
Rome 12
San Paolo di Civitate 12
Tianjin 12
Norwalk 11
Seongnam 11
Orange 10
Phoenix 9
Tehran 9
Guangzhou 8
Munich 8
Taizhou 8
Auburn Hills 7
Columbus 7
Hangzhou 7
San Mateo 7
Ancona 6
Brno 6
Lake Forest 6
Redwood City 6
Durham 5
Kunming 5
San Francisco 5
Tappahannock 5
Washington 5
Augusta 4
Central District 4
Changchun 4
Dakar 4
Düsseldorf 4
Fuzhou 4
Haikou 4
Lanzhou 4
Monreale 4
Napoli 4
Philadelphia 4
Pune 4
Taiyuan 4
Trapani 4
Venice 4
Verona 4
Agrigento 3
Atlanta 3
Bari 3
Berlin 3
Bremen 3
Castelnuovo Scrivia 3
Catania 3
Chicago 3
Chiswick 3
Frankfurt am Main 3
Hefei 3
Hong Kong 3
Hounslow 3
Indiana 3
Kilburn 3
Totale 5.556
Salva come PNG Salva come JPEG
Nome #
HCV genotypes in Sicily: is there any evidence of a shift? 238
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 186
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 178
Hepatitis B virus reactivation and alemtuzumab therapy 178
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 171
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 161
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 149
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 148
Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy 146
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 145
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance 143
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 141
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 140
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 139
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 138
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 136
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 132
Characterization of measles virus strains circulating in Southern Italy (Palermo area, Sicily) between 2010 and 2011 127
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 127
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 126
Hepatitis B virus reactivation and alemtuzumab therapy 124
Impact of HBV genotypes A and D genetic variability on infection evolution 122
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 119
RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO 117
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 116
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 114
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 114
Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis 110
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 106
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 105
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 104
Genotyping of Legionella pneumophila serogroup 1 strains isolated in Northern Sicily, Italy. 102
Triiodothyronine‐Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium 101
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 100
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 98
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors 96
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION 96
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients 95
Triiodothyronine accelerates the synthesis of Synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium 94
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION 94
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 93
IL-10 and TNF-α polymorphisms and the recovery from HCV infection 89
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 86
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 86
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study 85
Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis 85
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 83
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 82
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 81
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 79
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 77
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. 75
HCV genotypes in western Sicily: any evidence for a shift? 75
Infezione occulta da HBV in pazienti con malattie oncoematologiche 73
Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: the Camporeale model 72
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 72
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) 71
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 70
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 69
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 68
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis 68
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 67
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 67
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C 65
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 65
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination 64
RIATTIVAZIONE DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITÀ VIRALE 61
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 58
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 58
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 56
Evaluation of the diagnostic performances of two commercially available assays for the detection of enteric adenovirus antigens 56
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 55
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 55
Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition 53
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 52
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 52
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination 47
INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE 47
Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization 45
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE 43
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study 42
Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy 39
Liver follicular helper T-cells in chronic hepatitis C 32
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 31
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 30
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2 29
Atypical case of monkeypox with multiple bacterial skin superinfection 24
Do not forget mpox! 15
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France 12
Totale 8.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.086 0 0 0 0 0 232 219 133 195 94 145 68
2020/20211.045 62 88 154 86 69 43 56 61 153 82 75 116
2021/2022949 36 204 45 36 24 34 40 51 113 131 53 182
2022/20231.362 129 286 23 126 148 217 95 85 141 9 65 38
2023/2024561 35 65 44 71 61 114 37 23 14 16 10 71
2024/2025454 26 97 56 156 58 61 0 0 0 0 0 0
Totale 8.135